Articles Tagged With:
-
Preventing SARS-CoV-2 Infection with an Allergy Nasal Spray
Use of the antihistamine azelastine nasal spray was effective in preventing SARS-CoV-2 infection in young, healthy, vaccinated outpatients.
-
Patients Aged 6 Months and Older with Egg Allergy Should Receive Flu Vaccine
The Advisory Committee on Immunization Practices (ACIP) provided updated guidance for the 2025-2026 influenza season. After reviewing data on egg-based influenza vaccines, ACIP reinforced that individuals with egg allergies are not at increased risk of severe allergic reactions and outlined precaution and contraindication considerations in vaccine administration for this population.
-
Cost and Other Economic Factors Affect People’s Access to Contraceptives
New research examines how contraception costs can affect young people’s decision-making about whether to use contraception.
-
Cancer Survivors and Patients Need Individualized Contraceptive Counseling
Clinicians increasingly are gearing their contraceptive counseling to the specific needs and desires of each patient. Cancer patients and survivors need person-centered contraceptive counseling that is geared toward their bodies and circumstances.
-
Identifying Potential Missed Opportunities to Prevent Ovarian Cancer
A new study found that nearly one in four ovarian cancer patients with high-grade serous cancer (HGSC) could have been offered bilateral salpingectomy at the time of a prior abdominal surgery, potentially preventing their cancer diagnosis.
-
Contraceptives Have Multiple Protective Associations with Cancer
As clinicians and researchers work to improve contraception and women’s health, they can leverage their knowledge to help women access the method that works best for them — both as a contraceptive and also for other health benefits, such as cancer prevention.
-
Emerging Research Shows Cancer-Prevention Benefits of Contraceptives
Contraceptives have the potential to help patients with breast cancer, sickle cell disease, and even brain cancer.
-
Pediatric Trauma 2026 Is Here!
The latest installment in an award-winning series, Pediatric Trauma 2026: Procedural Sedation, Pain Control, and Trauma Care Essentials facilitates excellence by covering the latest scientific information on caring for children who present with traumatic injuries. Perfect for pediatric trauma programs, this book provides 18 hours of pediatric trauma-specific CME/CE credits, meeting the yearly requirements for trauma-certified professionals.
-
Brensocatib Tablets (Brinsupri)
The U.S. Food and Drug Administration has approved brensocatib, the first dipeptidyl peptidase-1 inhibitor and the first drug approved for non-cystic fibrosis bronchiectasis.
-
The Health and Economic Burden of Long COVID in the United States
Researchers using a computational simulation model found that the current health and economic burden of long COVID already exceeds the cost of several chronic diseases and will continue to grow as COVID-19 cases increase.